Why is JHS Sven.Lab. falling/rising?

As of 29-Aug, JHS Svendgaard Laboratories Ltd is experiencing a price increase, currently at 10.82, which reflects a change of 0.47 or 4.54% upward. Today's price summary indicates that the stock has outperformed its sector by 4.15% and has shown a trend reversal after three consecutive days of decline. However, it is important to note that the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a generally weak performance. Additionally, the stock has seen a significant drop in investor participation, with delivery volume falling by 33.47% compared to the 5-day average. The company has consistently underperformed against benchmarks, with a staggering -60.44% return over the past year, and has reported negative operating profit growth and weak debt servicing capabilities.
In the broader market context, JHS Svendgaard Laboratories Ltd's short-term performance shows a 1-week return of -1.64%, which is better than the Sensex's decline of -1.84%. Despite today's rise, the stock's long-term fundamentals remain weak, with a -5.77% CAGR growth in operating profits over the last five years and a negative EBITDA, indicating significant financial challenges. The company's reliance on non-operating income, which constitutes 158.73% of its profit before tax, raises concerns about its operational viability. Overall, while the stock has seen a short-term uptick, the underlying financial issues and historical underperformance suggest a cautious outlook.